constructing chimeric antigen for precise screening of htlv-i infection

نویسندگان

hafez heydari-zarnagh department of clinical biochemistry, faculty of medicine, sabzevar university of medical science, sabzevar, iran.

kazem hassanpour department of pediatrics, faculty of medicine, sabzevar university of medical science, sabzevar, iran.

mohammadjavad rasaee department of biotechnology, faculty of medical science, tarbiat modares university, tehran, iran.

چکیده

individual preparation of two human t-cell lymphotropic virus type i (htlv-i) diagnostic gst fused peptides (mta-1 and gd21) is time-consuming and expensive. the aim of this study was to design a novel single chimeric antigen (sca) to obviate separate expression of proteins and reduce the cost of reagent preparation.structural protein fragments, including immunodominant b cell linear epitopes, were selected and different scas were designed. tertiary structure, epitope exposure, solubility and stability were calculated for each sca and compared with each other. the synthetic dna  encoding  the  interested  sca  was  sub-cloned  into  pet32a  expression  vector, expressed as a soluble form in escherichia coli bl21 (de3) cells and purified under native condition using affinity chromatography.the sds-page results indicated that thioredoxin-fused sca was successfully expressed as a soluble form in e. coli bl21 (de3) cells. the results of elisa confirmed that sca reacted with anti-htlv-i antibodies in a concentration-dependent manner.our results indicated that the designed sca may be a good candidate for the screening of htlv-i carriers with antigen–antibody-based tests.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Constructing Chimeric Antigen for Precise Screening of HTLV-I Infection.

Individual preparation of two human T-cell lymphotropic virus type I (HTLV-I) diagnostic GST fused peptides (MTA-1 and GD21) is time-consuming and expensive. The aim of this study was to design a novel single chimeric antigen (SCA) to obviate separate expression of proteins and reduce the cost of reagent preparation. Structural protein fragments, including immunodominant B cell linear epitopes,...

متن کامل

expression and purification of recombinant htlv-i/-ii linear epitopes antigen and its application for screening of suspected patients

background and objectives: the linear epitopes of gp46-i, gp46-ii, gp21 and p19 are used in diagnosis of htlv-i/-ii infections. the aims of this study was to obtain high-level expression and purification of recombinant antigen (ra) containing these epitopes. large-scale preparation of such antigen probably worths for diagnostic purpose. materials and methods: the synthetic dna encoding ra was s...

متن کامل

Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella Infection

Brucellosis is a zoonotic disease in human and animals. Brucella melitensis is one of the most pathogenic species of Brucella in goat and sheep. Omp31 is an outer membrane protein of Brucella that acts as an immunogenic protein. Cytokines are glycoproteins with low molecular weight that play the role of an immune adjuvant and regulate immune responses. Interleukin-2 is one of the most important...

متن کامل

Screening of Sera for Anti-htlv-i Antibodies

Serum antibodies against human T cell leukaemia virus type I (HTLV-I) were investigated in 12 patients by four methods: indirect immunoperoxidase staining, indirect immunofluorescence, enzyme linked immunosorbent assay (ELISA), and strip radioimmunoassay based on the Western blotting assay. Seven patients had systemic lupus erythematosus (SLE) and five various autoimmune diseases with one or mo...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of allergy, asthma and immunology

جلد ۱۴، شماره ۴، صفحات ۴۲۷-۴۳۶

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023